Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy

• Main Authors: Cecilia Fazio (Author), Alessia Biolchi (Author), Arianna Neri (Author), Sara Tomei (Author), Paola Vacca (Author), Luigina Ambrosio (Author), Annapina Palmieri (Author), Elena Mori (Author), Rita La Gaetana (Author), Mariagrazia Pizza (Author), Marzia Monica Giuliani (Author), Laura Serino (Author), Paola Stefanelli (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invasive meningococcal disease (IMD) and may potentially offer protection against strains belonging to non-B serogroups. This study aimed to evaluate the ability of 4CMenB-...